Stifel Reiterates Buy Rating on Profound Medical Corp. (PROF)
Tweet Send to a Friend
Stifel analyst Rick Wise reiterated a Buy rating and $12.00 price target on Profound Medical Corp. (NASDAQ: PROF).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


